Teva has launched a new biannual Startup Challenge Program to identify innovative technological solutions that can be applied across the pharmaceutical value chain – including drug discovery, development, production, and supply.
The program is open to startups from Israel and abroad, with selected participants receiving pilot funding and the opportunity to collaborate with Teva’s internal teams. Through this initiative, Teva aims to expand its innovation channels and deepen its engagement with the global startup ecosystem.